RxDoctor Payments Data

Karl Ilg, MD

Clinical Cardiac Electrophysiology · Detroit, MINPI 1336267723

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medical Device Business Services, Inc. at 32.3% of the total.

$28,608in general payments, 2019–2025

Across 161 payments — averaging $177.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$9K
  • Medtronic$6K
  • Biosense Webster, Inc.$6K
  • Philips North America LLC$4K
  • Abbott$2K
  • Boston Scientific$421
  • plus $811 from 14 others
$28,720in research payments, 2019–2025

Across 49 payments — averaging $586.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$15K
  • Atricure, Inc.$7K
  • Biotronik Inc.$6K

What the payments were for

  • Consulting fees$12,55044%
  • Speaking & faculty fees$2,4008%
  • Travel & lodging$7,15825%
  • Food & beverage$6,49923%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,608 in reported general payments places this provider in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

See all clinical cardiac electrophysiology providers in Michigan

Medicare billing

Part B allowed, 2024
$96,830
Medicare patients
219
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban105$127,820
XareltoRivaroxaban13$19,470
Flecainide Acetate31$1,318
Amiodarone Hcl46$1,131
Metoprolol Succinate42$733
SotalolSotalol Hcl20$494
Warfarin Sodium22$424
Metoprolol Tartrate22$211

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$37$19,47013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.

Other clinical cardiac electrophysiology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →